Search results for: 'disease burden'
- Did you mean
- disease border
- Related search terms
- disease diagnosis nmr metabolomics
- disease management software
- disease of invest
- disease monitoring in invest
- disease diagnosis ndr metabolomics
-
08 Jul 2026  |  Global  |  Technology Research
Digital Therapeutics for Chronic Conditions
From Apps to Digital Interventions to Clinically-Regulated Prescription Digital Therapeutics
This research study evaluates the evolving global digital therapeutics (DTx) ecosystem, with a focused analysis on Cognitive DTx and Metabolic DTx. The study examines the transition of DTx from emerging digital health tools toward clinically validated, interoperable, and scalable therapeutic platforms integrated within broader healthcare ecosystems...
$4,950.00 -
23 Aug 2019  |  Global  |  Technology Research
Emerging Therapeutics for Neurodegenerative Diseases, Part I: Novel Targeted Therapeutic Strategies Technologies for Alzheimer's and Parkinson's Diseases
Novel Targeted Therapeutic Strategies Technologies Around Neurodegenerative Disorders - From Palliative to Future Interventions
At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...
$4,950.00 -
16 Dec 2021  |  Global  |  Technology Research
Emerging Technology Innovations and Growth Opportunities Enabling the Self-Monitoring of Health: The Way to Healthcare Consumerism
Disruptive Self-Disease Management Platforms Are Enabling Better Clinical Outcomes in Chronic Illnesses.
Self-health monitoring products and technologies boost consumer awareness of their health and help them to monitor it, avail timely medical help, and lead a high-quality life. Tools such as wearables, body patches, smartphone applications, lateral flow assays, and other peripheral devices are used to diagnose acute conditions, help patients reach t...
$4,950.00 -
14 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028
GLP-1 RA Drug Class, Combination Therapies, and Digital Convergence for Affordable Disease Management Drive Growth
Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...
$4,950.00 -
29 Jun 2018  |  Global  |  Technology Research
Novel Therapies for Rare and Genetic Diseases
Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy
Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...
$4,950.00 -
09 Nov 2022  |  Global  |  Technology Research
Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis
Strategic partnering and new product development will enable better biologics for personalized and targeted treatment
Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases, hereditary ataxias, peripheral nerve disorders, neuromuscular junction transmission disorders, and myopathies. NMDs prese...
$4,950.00 -
13 Oct 2021  |  Global  |  Technology Research
Global Neurological Therapies Growth Opportunities
Need for Effective Palliative Management Driving Technology Advances in Neurological Disease Drug Development
Neurological diseases refer to disorders of the brain, nerves, and spinal cord that lead to structural, biochemical, or electrical complications in the body. Major causes of neurological disorders include brain, spinal cord, or nerve injury; genetic disorders; congenital abnormalities; infections; and lifestyle. Neurological diseases include an ext...
$4,950.00 -
13 Dec 2024  |  Global  |  Technology Research
Recent Innovations in Precision Medicine Innovations for Cancer and Immunological Diseases
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provide insights across new biologics, and precision cancer therapy innovations. The research also comprises small molecule, cell and gene therapy and gene editing advancements for Niemann–Pick Disease and autoimmune diseases.The Life Science, Health & Wellness ...
$950.00 -
21 Mar 2025  |  Global  |  Technology Research
Recent Advances in Therapies for Cancer, Rare Diseases, Mental Health and Infections
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides innovation insights across cell and gene therapy advances. The TOE also encompasses recent therapy developments for neuropsychiatric, rare, and infectious diseases. The research covers recent advances in vaccines and biomanufacturing platforms.The Life ...
$950.00 -
06 Jun 2018  |  Global  |  Market Research
Cardiometabolic Diseases Market—Trends and Growth Opportunities, Forecast to 2022
Shift Towards a 'Comprehensive Care Continuum' with the Adoption of Integrated Care Pathways that Combine Clinical Therapies with Wellness Programs
Globally, cardiometabolic diseases are witnessing a consistent rise in prevalence every year, with hypertension and diabetes among the leading conditions. A rising population of hypertension is, in turn, leading to growing incidence of chronic heart failure with about 26 million cases of CHF globally. Although drug therapies are the first line of t...
$4,950.00